Genaissance Pharmaceuticals, Inc. Invites You to Participate in its First Quarter 2005 Conference Call
26 Abril 2005 - 10:00AM
PR Newswire (US)
Genaissance Pharmaceuticals, Inc. Invites You to Participate in its
First Quarter 2005 Conference Call NEW HAVEN, Conn., April 26
/PRNewswire-FirstCall/ -- Genaissance Pharmaceuticals, Inc.
(NASDAQ:GNSC) today announced that the Company would conduct a
conference call on Tuesday, May 3, 2005, at 11:00 a.m. Eastern time
(ET), in conjunction with the release of its financial results for
the first quarter ended March 31, 2005. To participate in this
conference call, dial 719-457-2629, confirmation code 4544361,
shortly before 11:00 a.m. ET. A replay of the call will be
available from 2:00 p.m. ET through midnight Monday, May 9, 2005.
The replay number is 719-457-0820, confirmation code 4544361.
Genaissance Pharmaceuticals, Inc. is developing innovative products
based on its proprietary pharmacogenomic technology and has a
revenue-generating business in DNA and pharmacogenomic products and
services. Genaissance also markets its proprietary FAMILION(TM)
Test, designed to detect mutations responsible for causing Familial
Long QT and Brugada Syndromes, two causes of sudden cardiac death.
The Company's product development strategy is focused on drug
candidates with promising clinical profiles and finding genetic
markers to identify a responsive patient population. This strategy
is designed to enable Genaissance to leverage existing clinical
data and, thus, reduce the costs and risks associated with
traditional drug development and increase the probability of
clinical success and commercialization. The Company's lead
therapeutic product, vilazodone for depression, is in Phase II of
development. For more information on Genaissance, visit the company
website at: http://www.genaissance.com/. DATASOURCE: Genaissance
Pharmaceuticals, Inc. CONTACT: Rhonda Chiger, +1-917-322-2569, of
Rx Communications Group, for Genaissance Pharmaceuticals, Inc. Web
site: http://www.genaissance.com/
Copyright
Genaissance (NASDAQ:GNSC)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Genaissance (NASDAQ:GNSC)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024
Real-Time news about Genaissance Pharmaceuticals (MM) (NASDAQ): 0 recent articles
Más de Genaissance Pharmaceuticals, (MM) Artículos de Noticias